The Central Epidemic Command Center (CECC) is planning to launch a public-private partnership to develop and produce antibody treatments against COVID-19, according to the National Health Research Institutes (NHRI).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Guangfu reconstruction meeting marred by disorder, political spats
10/28/2025 02:28 PM - Business
Hon Hai to invest NT$42 billion in AI computing equipment
10/28/2025 02:17 PM - Business
Taiwan shares close down 0.16%
10/28/2025 01:55 PM - Culture
Documentary on Czech Senate president's visit to Taiwan debuts in Prague
10/28/2025 01:24 PM - Politics
Taiwan launches global initiative on security of undersea cables
10/28/2025 11:57 AM